Phase II trial of buserelin in hepatocellular carcinoma
- 30 September 1989
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (9), 1339-1340
- https://doi.org/10.1016/0277-5379(89)90083-7
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosteroneEuropean Journal of Cancer and Clinical Oncology, 1987
- Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humansCancer, 1986